• British-Butcher-Shoppe.jpg
  • Johnstones-BBQ-scaled.jpg
  • Escape-Travel-scaled.jpg
  • Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • About Us
  • Advertise
  • Contact
  • Send news and story ideas
  • News Alerts
ADVERTISE WITH US
North Shore Daily Post

North Shore Daily Post

Follow Us

Local News for North Vancouver and West Vancouver

Saturday July 5, 2025
  • HOME
  • North Shore
  • Vancouver
  • Life
  • BC/Canada
  • Voices
  • Support Us
  • New-cannabis.png
  • swad-ad-revised.jpg

Vancouver company receives $175 million from feds to develop COVID-19 treatment

STAFF REPORT
May 3, 2020 10:20am

Government of Canada is giving $175.6 million to AbCellera Biologics, a Vancouver-based biotechnology company that researches and discovers next-generation antibody drugs to fight infection and disease.

“This contribution is part of Canada’s Plan to Mobilize Science to fight COVID-19, announced on March 23, 2020, which includes significant investments in Canada’s world-class research community to develop vaccines and treatments for COVID-19 and to diagnose the disease,” said Navdeep Bains, Minister of Innovation, Science and Industry.

AbCellera’s drug discovery technology searches and analyzes blood samples of recovered patients to rapidly find naturally produced antibodies that can be used to fight and prevent viral infections.

In just a few short weeks, AbCellera has identified over 500 antibodies directly from a patient who has recovered from COVID-19.

AbCellera and its partners expect clinical trials to begin in July 2020 or earlier.

Antibodies found during AbCellera’s research may also be used to create tests for COVID-19, and the company is working with several global organizations to support the development of new diagnostics to monitor the disease.

This funding will also support AbCellera in establishing a Good Manufacturing Practice (GMP) facility in Vancouver, B.C.

This new AbCellera facility will be the first of this scale in Canada capable of going from a patient sample to manufacturing antibodies for clinical testing.

It is part of a broader plan to ensure Canada further strengthens its capacity to respond to future pandemics, the government said.

Share

Reader Interactions

Comments

NOTE: The North Shore Daily Post welcomes your opinions and comments. We do not allow personal attacks, offensive language or unsubstantiated allegations. We reserve the right to edit comments for length, style, legality and taste and reproduce them in print, electronic or otherwise. For further information, please contact the editor or publisher, or see our Terms and Conditions.

No Comments

Leave a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Coast-Consignment-VERTICAL.jpg

Recommended Stories

https://www.northshoredailypost.com/wp-content/uploads/2022/04/scam-400x262.jpg
BC/Canada
BC woman loses over $23,000 in romance scam
https://www.northshoredailypost.com/wp-content/uploads/2018/01/CNV-MAIN-400x225.jpg
North Shore
Want to remove a tree ? CNV has a new tree bylaw
https://www.northshoredailypost.com/wp-content/uploads/2021/05/quarry-rock-400x229.jpg
North Shore
Popular North Vancouver trail will likely remain closed this summer
https://www.northshoredailypost.com/wp-content/uploads/2022/03/new-tech-400x231.jpg
North Shore
DNV using new technology to grow trees in Deep Cove
https://www.northshoredailypost.com/wp-content/uploads/2021/11/Douglas-Fur-Capilano-river-park-400x286.jpg
North Shore
VIDEO: A fallen 500-yr-old Douglas fir in North Vancouver still gives back

Footer

Contact Us: contact@northshoredailypost.com

Follow Us

Copyright ©2020 North Shore Daily Post. All Rights Reserved
  • About Us
  • Advertise
  • Privacy Policy
  • Terms and Conditions
 

Loading Comments...